LUBIPROSTONE相关论文
据报道,美国FDA已经批准苏坎泊制药公司(Sucampo Pharmaceuticals)开发的慢性便秘治疗药Amitiza(通用名:lubiprostone)增加一项适......
据报道,美国FDA已经批准苏坎泊制药公司(Sucampo Pharmaceuticals)开发的慢性便秘治疗药Amitiza(通用名:lubiprostone)增加一项适......
目的建立液相色谱-串联质谱法测定鲁比前列酮胶囊的溶出度,对鲁比前列酮胶囊的质量进行控制。方法以15-羟基十五酸为内标物,采用De......
尼罗替尼Nilotinib；鲁比前列酮lubiprostone；雷萨吉兰Rasagiline；环索奈德Cicmesonide；磷酸西他列汀Sitagliptin phosphate。......
Lubiprostone是2006年1月经FDA批准上市，用于治疗成人慢性特发性便秘症的新药。该药由Sucampo制药公司研制，并经Sucampo制药公司与北......
为管理便秘在的很多新、新奇策略老出现在过去几年。Prucalopride 是一个如此的新代理人在管理长期的便秘是高度有效的。事实上，在......
Ischemic colitis accounts for 6%-18% of the causes of acute lower gastrointestinal bleeding.It is often multifactorial a......
Lubiprostone vs Senna in postoperative orthopedic surgery patients with opioid-induced constipation:
AIM:To investigate the efficacy of lubiprostone compared to Senna on bowel symptoms and constipation in post-operative o......
目的:建立了高效液相色谱法测定具有烯醇互变结构的鲁比前列酮有关物质方法。方法:采用LiChrospher 100Diol,(250mm×4.0mm,5......
AIM:To study the efficacy and safety of pharmacolo-gical treatment of constipation in geriatrics.METHODS:Pub Med,MEDLINE......
AIM: To assess the additive effect of lubiprostone on the quality of colon preparation in diabetics given single-dosed p......
In comparison to polyethylene glycol,lubiprostone offers other advantages and is increasingly being used as an adjunctiv......
In comparison to polyethylene glycol,lubiprostone offers other advantages and is increasingly being used as an adjunctiv......
Background: The efficacy of lubiprostone for chronic constipation has been established through phase III clinical trials......
据报道，美国FDA已经批准苏坎泊制药公司（Sucampo Pharmaceuticals）开发的慢性便秘治疗药Amitiza（通用名：lubiprostone）增加一项适应证—......
肠易激综合征是一种常见的功能性胃肠道疾病，便秘型IBS因其症状顽固且无特效药物治疗引起更多关注。Lubiprostone（商品名Amitiza）是一......
Sucampo药物公司已经在美国提交了治疗慢性特发性便秘和有关症状的新药lubiprostone（Ⅰ）的申请。......
美国FDA于2006年1月份批准了下述几件NDA申请。它们是Sutent、RotaTeq、lubiprostone和ranolazine。...
Sucampo制药公司已报道了其胃肠道用药lubiprostone（Ⅰ）用于治疗慢性非癌痛患者阿片引起的肠功能紊乱（OBD）的两项Ⅲ期研究的主要结果。......
